Cargando…
Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary--a new therapeutic approach?
Autores principales: | Malik, S. T., Slevin, M. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971854/ https://www.ncbi.nlm.nih.gov/pubmed/1825918 |
Ejemplares similares
-
A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.
por: Downer, S., et al.
Publicado: (1993) -
An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer.
por: Johnson, J. R., et al.
Publicado: (1984) -
Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity
por: Jia, Xiangxu, et al.
Publicado: (2021) -
Progestagens for granulosa cell tumours of the ovary.
por: Isaacs, R., et al.
Publicado: (1992) -
Hypercalcemia after the Discontinuation of Medroxyprogesterone Acetate
por: Yuasa-Shibasaki, Erina, et al.
Publicado: (2017)